Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-26-014230
Filing Date
2026-04-30
Accepted
2026-04-30 16:25:32
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 18362
  Complete submission text file 0001437749-26-014230.txt   20165
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
Stablecoin Development Corp (Subject) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 26925961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 600 MONTGOMERY STREET, 42ND FLOOR SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, 42ND FLOOR SAN FRANCISCO CA 94111 (628) 233-0357
Framework Ventures IV L.P. (Filed by) CIK: 0002028474 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A